ブドウ球菌ワクチン
WordNet
- immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
- of or relating to the staphylococcus bacteria; "a staphylococcal infection"
PrepTutorEJDIC
- 牛痘種,痘苗(牛痘を起こすビールスで,天然痘予防のために人体に接種される) / (伝染病の病原菌から作った)ワクチン
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus.
- Thammavongsa V1, Rauch S1, Kim HK1, Missiakas DM1, Schneewind O2.
- Vaccine.Vaccine.2015 Jan 15;33(4):523-6. doi: 10.1016/j.vaccine.2014.11.051. Epub 2014 Dec 6.
- Staphylococcus aureus is a cause of sepsis and meningitis in very-low-birth-weight (VLBW) infants. Clinical trials with S. aureus specific antibodies failed to protect VLBW neonates, which may be due to the immune evasive attributes of staphylococcal protein A (SpA). Here we show that mouse monoclon
- PMID 25488332
- Recombinant ESAT-6-Like Proteins Provoke Protective Immune Responses against Invasive Staphylococcus aureus Disease in a Murine Model.
- Zhang BZ1, Hua YH2, Yu B2, Lau CC3, Cai JP3, Zheng SY2, Yam WC3, Kao RY3, Sze KH3, Zheng BJ3, Yuen KY4, Huang JD5.
- Infection and immunity.Infect Immun.2015 Jan;83(1):339-45. doi: 10.1128/IAI.02498-14. Epub 2014 Nov 3.
- Staphylococcus aureus is a common pathogen found in the community and in hospitals. Most notably, methicillin-resistant S. aureus is resistant to many antibiotics, which is a growing public health concern. The emergence of drug-resistant strains has prompted the search for alternative treatments, su
- PMID 25368117
- Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.
- Yeaman MR1, Filler SG2, Chaili S3, Barr K4, Wang H3, Kupferwasser D3, Hennessey JP Jr5, Fu Y2, Schmidt CS5, Edwards JE Jr2, Xiong YQ2, Ibrahim AS2.
- Proceedings of the National Academy of Sciences of the United States of America.Proc Natl Acad Sci U S A.2014 Dec 23;111(51):E5555-63. doi: 10.1073/pnas.1415610111. Epub 2014 Dec 8.
- Increasing rates of life-threatening infections and decreasing susceptibility to antibiotics urge development of an effective vaccine targeting Staphylococcus aureus. This study evaluated the efficacy and immunologic mechanisms of a vaccine containing a recombinant glycoprotein antigen (NDV-3) in mo
- PMID 25489065
Japanese Journal
- Immunization with nontoxic mutant staphylococcal Enterotoxin a protects against Enterotoxin-induced emesis in house musk shrews. [Emerging Frontiers in Brain Research: Crossroads of metabolic regulaltion, stress response and disease. The 11th Meeting of Hrosaki International Forum of Medical Science. Communication Center of Hirosaki University School of Medicine. March 27-28,2009. Hirosaki, Japan.]
- Vaccination with a Nontoxic Mutant of Staphylococcal Enterotoxin C Elicits TH2 Immune Response for Protection against Staphylococcus Aureus Infection [Emerging Theories of Host Defense. The 10th Meeting Hirosaki International Forum of Medical Science. Communication Center Hirosaki University School of Medicine. Hirosaki on November 21-22, 2006]
- アジュバントがウサギにおけるブドウ球菌性アルファ毒素および夾膜性多糖の免疫反応に及ぼす影響
- The journal of veterinary medical science 62(3), 237-241, S・iii-S・iV, 2000-03-25
- NAID 110003920303
Related Links
- ABSTRACT Staphylococcal infections are a major source of global morbidity and mortality. Currently there exists no anti-staphylococcal vaccine in clinical use. Previous animal studies suggested a possible role for ...
- Abstract: The vaccine that is protective against pathogenic bacterial species, typically staphylococcal species, and including methods to prepare said vaccine and to culture pathogenic bacteria. Claims: 1. A composition ...
Related Pictures
★リンクテーブル★
[★]
- 英
- staphylococcal vaccine
[★]
- 関
- staphylococci、Staphylococcus